- Six coronavirus vaccine candidates have been determined to be the likeliest to succeed, a Morgan Stanley analyst said in a recent note to investors.
- The list of candidates includes a few familiar names, like Moderna, Oxford, and BioNTech. These labs are already conducting promising human trials, and the drugs could be approved later this year.
- Other vaccine candidates from Johnson & Johnson and Sanofi could be ready by the end of 2021.
- Visit BGR’s homepage for more stories.
There’s no cure for the novel coronavirus right now, but significant progress is being made. Physicians treating COVID-19 patients have been able to discover all sorts of unusual symptoms and come up with treatments that can speed up recovery and reduce complications. Similarly, vaccine research looks incredibly promising.
We have no idea if a vaccine will be able to generate the desired immune response and block infection, but more than 100 teams came forward with ideas on how to stop the virus. As many as eight of them are already in various phases of clinical trials, and at least a couple of them could be approved for emergency use as soon as this fall. Of all of them, analysts at Morgan Stanley think that six of the existing candidates are the most likely to succeed.
Today’s Top Deals
- Today’s best deals: Apple Watch and AirPods Pro at all-time lows, 70¢ face masks, $18 Wi-Fi extender, $20 earbuds, more
- $50 accessory makes your home internet so much faster
- Today’s top deals: Coronavirus face masks, toilet paper, protein bars, $20 Bluetooth earbuds, $18 Wi-Fi extender, more
Trending Right Now:
- Chinese doctors say they may be able to cure coronavirus without a vaccine
- You can now call the IRS with questions about your stimulus check
- Huge leak reveals the release date and price of Apple’s AR glasses
These are the 6 most promising coronavirus vaccine candidates originally appeared on BGR.com on Tue, 19 May 2020 at 14:53:36 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report